# ATG Combined With Cyclophosphamide And Cord Blood Transfusion in Treating Patients With Severe Aplastic Anemia

> **NCT02838992** · PHASE4 · UNKNOWN · sponsor: **Jinan Military General Hospital** · enrollment: 130 (estimated)

## Conditions studied

- Aplastic Anemia

## Interventions

- **DRUG:** Rabbit ATG, (Genzyme)
- **DRUG:** Cy
- **DRUG:** CsA
- **BIOLOGICAL:** Cord blood

## Key facts

- **NCT ID:** NCT02838992
- **Lead sponsor:** Jinan Military General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-02
- **Primary completion:** 2018-12
- **Final completion:** 2019-07
- **Target enrollment:** 130 (ESTIMATED)
- **Last updated:** 2017-02-01

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02838992

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02838992, "ATG Combined With Cyclophosphamide And Cord Blood Transfusion in Treating Patients With Severe Aplastic Anemia". Retrieved via AI Analytics 2026-06-07 from https://api.ai-analytics.org/clinical/NCT02838992. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*